- Home
- Catalog
- Growth hormone axis
- CJC-1295 (with DAC)
peptide
CJC-1295 (with DAC)
A GHRH analogue conjugated to a drug-affinity complex for extended half-life.
CJC-1295 (with DAC) · 5 mg · Lyophilised vial
peptide
CJC-1295 (with DAC)
A GHRH analogue conjugated to a drug-affinity complex for extended half-life.
In stock
What it is
CJC-1295 with DAC carries a maleimidopropionic-acid linker that binds the peptide to serum albumin after administration in research models, extending its half-life to days rather than minutes. It is otherwise the same tetra-substituted GHRH(1-29) analogue.
Where it has been studied
Literature search: PubMed, "CJC-1295 DAC albumin". The areas listed describe published research, not outcomes.
- Sustained GHRH receptor activation models
- Growth hormone and IGF-1 axis studies
- Albumin-binding peptide pharmacokinetics
Specifications
| Compound | CJC-1295 (with DAC) |
|---|---|
| Type | Peptide |
| Selected presentation | 5 mg · Lyophilised vial |
| Form | Lyophilised powder in a sealed glass vial |
| Fill volume and concentration | Not applicable (lyophilised) |
| Label | CELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only" |
| Storage | -20 °C for long-term storage; 2 to 8 °C for under three months; away from light |
| Certificate of analysis | Not yet published online. Request for a batch |
| Research areas | Growth hormone axis |
| All presentations | 5 mg lyophilised vial · € 45.00 10 mg lyophilised vial · € 50.00 |
Handling
- Lyophilised peptides tolerate room temperature for several weeks in transit. Move to cold storage on receipt.
- Reconstituted vials are typically used within three to four weeks at 2 to 8 °C; stability varies by compound.
- Opened or unsealed vials cannot be returned. Transit damage must be documented within 24 hours.





